Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues
Reexamination Certificate
2007-09-18
2007-09-18
Harris, Alana M. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
C530S300000, C536S001110, C536S024100, C536S024200, C536S024310, C436S064000, C435S004000, C435S069100, C435S320100, C435S325000
Reexamination Certificate
active
09809638
ABSTRACT:
A novel gene (designated 125P5C8) and its encoded protein are described. While 125P5C8 exhibits tissue specific expression in normal adult tissue, it is aberrantly expressed multiple cancers including prostate, bladder, kidney and colon cancers. Consequently, 125P5C8 provides a diagnostic and/or therapeutic target for cancers, and the 125P5C8 gene or fragment thereof, or its encoded protein or a fragment thereof used to elicit an immune response.
REFERENCES:
patent: 2211504 (1989-07-01), None
patent: WO-01/75067 (2001-10-01), None
patent: WO-01/94629 (2001-12-01), None
patent: WO-02/10449 (2002-02-01), None
patent: WO-02/26982 (2002-04-01), None
patent: WO-02/055700 (2002-07-01), None
patent: WO02068677 (2002-09-01), None
patent: WO02070539 (2002-09-01), None
patent: WO 02070539 (2002-09-01), None
patent: WO02072785 (2002-09-01), None
patent: WO03050236 (2003-06-01), None
Lazar et al. Transforming Growth Factor alpha: Mutation of Aspartic Acid 47 and Leucine 48 Results in Different Biological Activities. Molecular and Cellular Biology 8(3): 1247-1252, Mar. 1988.
Tockman et al. Considerations in Bringing a Cancer Biomarker to Clinical Application. Cancer Research (Suppl.) 52: 2711s-2718, May 1, 1992.
GenCore databases, Amino acid and nucleic acid databases, SEQ ID No. 1 and 2, Accession numbers Q9H720 and AK025164, ten sheets. Mar. 2001 and Sep. 2000.
Hubert et al., Proc. Natl. Acad. Sci. USA (1999) 96(25):14523-14528.
Klein et al., Nat. Med. (1997) 3:402.
Pinto et al., Clin. Cancer Res. (1996) 2(9):1445-1451.
Reiter et al., Proc. Natl. Acad. Sci. USA (1998) 95:1735.
Su et al., Proc. Natl. Acad. Sci. USA (1996) 93:7252.
Howell, Molecular Urology (1999) 3(3):295-302.
Jain, Cancer and Metastasis Reviews (1990) 9:253-266.
Alberts et al., Molecular Biology of the Cell, 3rd edition, Garland Publishing, Inc. (1994) p. 465.
Fu et al., EMBO Journal (1996) 15:4392-4401.
Lewin, Genes VI, Oxford University Press, Inc., New York (1997) Chapter 29.
Mallampalli et al., Biochem J. (1996) 318:333-341.
Greenbaum et al., Genome Biology (2003) 4(9):117.1-117.8.
Tockman et al., Cancer Res. (1992) 52:2711s-2718s.
McNeil, JNCI 90(12):882-883 Jun. 17, 1998.
Prewett et al., Clinical Cancer Research (1998) 4:2957-2966.
Abdel-Malek, J. Cell Physiol. (1988) 136:247.
Abe and Saito, J. Neurochem. (2001) 76:217-223.
Batra et al., Prostate. (1991) 19:299.
Chen, Current Opinion in Immunology (1999) 11(2):219-222.
Craft et al., Cancer Res. (1999) 59:5030-5036.
Database Uniprot, Accession No. Q9H720 (Mar. 2001).
Davies et al., Science (2000) 290:2295.
Filetti et al., Eur. J. Endocrinol. (1999) 141:443.
Fu et al., Int. J. Cancer (1992) 52(6):987-990.
Gergely et al., Clin. Diagn. Lab. Mannual (1997) 4:70.
Hollo et al., Biochimica et Biophysica Acta (1994) 1191:384.
Hubert et al., Proc. Natl. Acad. Sci. USA (1999) 96(25):14523-14528.
Ivanov and Ronai, Oncogene (2000) 19:3003.
Janulis et al., J. Biol. Chem. (1999) 274:801.
Krueger et al., Cancer Res. (1999) 59:6010.
Kaighn et al., Invest. Urol. (1979) 17(1):16-23.
Klein et al., Nature Med. (1997) 3:402-408.
Kubota, J. Cell Biochem. (1994) 56(1):4-8.
Leith et al., Blood (1995) 86:2329.
Linsley et al., J. Exp. Med. (1991) 174:561-566.
Mirza et al. Cell Growth Differ. (2000) 11:279.
Morton and Myszka, Methods in Enzymology (1998) 295:268.
Musil et al., J. Biol. Chem. (2000) 275:25207.
Pemberton et al., J. of Histochemistry and Cytochemistry (1997) 45:1697-1706.
Saffran et al., PNAS (2001) 98(5):2658-2663.
Skryma et al., J. Physiol. (2000) 527:71.
Spitzweg et al., Cancer Res. (2000) 60:6526.
Storrie et al., Methods Enzymol. (1990) 182:203-225.
Supplementary Partial European Search Report for EP 02726630.3, Mailed on Jan. 10, 2007, 4 pages.
Tazebay et al., Nat. Med. (2000) 6:871.
Welford, Opt. Quant. Elect. (1991) 23:1.
Chen, Current Opinion in Immunology (1999) 11(2):219-222.
Database UniProt, accession No. Q9H720 (Mar. 2001).
Supplementary Partial Europen Search Report for EP 02726630.3, mailed on Jan. 10, 2007, 4 pages.
Afar Daniel E. H.
Challita-Eid Pia M.
Faris Mary
Jakobovits Aya
Mitchell Steve Chappell
Agensys, Inc.
Harris Alana M.
Morrison & Foerster / LLP
LandOfFree
125P5C8: a tissue specific protein highly expressed in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 125P5C8: a tissue specific protein highly expressed in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 125P5C8: a tissue specific protein highly expressed in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3799398